Health economics and stopping eculizumab treatment safely
A second article in a series of four planned has just been published. It is about the health economics of treatment…
A second article in a series of four planned has just been published. It is about the health economics of treatment…
In the ever-evolving world of rare disease advocacy, each milestone marks not just progress, but hope. Today, hope takes on a…
Once upon a time, far away in the middle of a sparkling sea, there was a magical island called Camp-le-mont. Some…
It is over a decade ago now but I still recall vividly when, at the first meeting of what would become…
India has had its first patient conference. A summary of what was covered has been posted on line and reposted below.…
Frequently these days people talk about their "journey". I have known of the journey of an aHUS patient in India for…
When it comes to advocacy why say there is aHUS and there is also aHUSs? The rare disease aHUS is described…
Imagine atypical haemolytic uraemic syndrome or aHUS on a well know quiz show, say Mastermind. How would it look?--- The Mastermind…
A PDA or patient decision aid is becoming an important part of the increasing shared decision making by patients and doctors.…